Preparation and dissolution profiles of the amorphous, dihydrated crystalline, and anhydrous crystalline forms of paclitaxel

Drying Technology

Volumn 25, Issue 10, 2007, Pages 1759-1767

  Pyo, Sang Hyun ^a,b   Cho, Jin Suk ^a   Choi, Ho Joon ^a   Han, Byung Hee ^b  

^a Samyang Corporation   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

Amorphous paclitaxel; Anhydrous crystalline paclitaxel; Dihydrated crystalline paclitaxel; Dissolution rate; Morphology

Indexed keywords

COLLOIDS; CRYSTALLINE MATERIALS; DISSOLUTION; POLYMORPHISM; PRECIPITATION (CHEMICAL); SPRAY DRYING;

COLLOID FORMATION METHOD; DISSOLUTION RATE;

DRUG PRODUCTS;

COLLOIDS; CRYSTALLINE MATERIALS; DISSOLUTION; DRUG PRODUCTS; POLYMORPHISM; PRECIPITATION (CHEMICAL); SPRAY DRYING;

EID: 34848847837     PISSN: 07373937     EISSN: 15322300     Source Type: Journal    
DOI: 10.1080/07373930701593180     Document Type: Article

References (27)

1. Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P. and McPhail, A. T. (1971) Plant antitumor agents, VI: The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. Journal of the American Chemical Society, 93, pp. 2325-2327.
2. McGuire, W. P., Rowinsky, E. K., Rosenshein, N. B., Grumbine, F. C., Ettinger, D. S., Armstrong, D. K. and Donehower, R. C. (1989) Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Annals of Internal Medicine, 111, pp. 273-279.
3. Rowinsky, E. K., Cazenave, L. A. and Donehower, R. C. (1990) Taxol: A novel investigational antimicrotubule agent. Journal of the National Cancer Institute, 82, pp. 1247-1259.
4. Arbuck, S. G., Christian, M. C., Fisherman, J. S., Cazenave, L. A., Sarosy, G., Suffness, M., Adams, J., Canetta, R., Cole, K. E. and Friedman, M. A. (1993) Clinical development of Taxol. Journal of the National Cancer Institute Monographs, 15, pp. 11-24.
5. Liggins, R. T., Hunter, W. L. and Burt, H. M. (1997) Solid-state characterization of paclitaxel. Journal of Pharmaceutical Sciences, 86, pp. 1458-1463.
6. Waugh, W. N., Trissel, L. A. and Stella, V. J. (1991) Stability, compatibility and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers. American Journal of Hospital Pharmacy, 48, pp. 1520-1544.
7. Onetto, N., Canett, R., Winograd, B., Catane, R., Dougan, M. and Grechko, J. (1993) Overview of Taxol safety. Journal of the National Cancer Institute Monographs, 15, pp. 131-139.
8. Mazzo, D., Nguyen-Huu, J. J., Pagniez, S. and Denis, P. (1997) Compatibility of docetaxel and paclitaxel in intravenous solutions with polyvinyl chloride infusion materials. American Journal of Health-System Pharmacy, 54, pp. 566-569.
9. Crosasso, P., Ceruti, M., Brusa, P., Arpicco, S., Dosio, F. and Cattel, L. (2000) Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. Journal of Controled Release, 63, pp. 19-30.
10. Dordunoo, S. K. and Burt, H. M. (1996) Solubility and stability of toxol: Effects of buffer and cyclodextrins. International Journal of Pharmaceutics, 133, pp. 191-201.
11. Re, M.-I. (2006) Formulating drug delivery systems by spray drying. Drying Technology, 24, pp. 433-446.
12. Kemp, I. C. (2004) Drying in the context of the overall process. Drying Technology, 22, pp. 377-394.
13. Beaudry, C., Raghavan, G. S. V., Ratti, C. and Rennie, T. J. (2004) Effect of four drying methods on the quality of osmotically dehydrated cranberries. Drying Technology, 22, pp. 521-539.
14. Hancock, B. C. and Parks, M. (2000) What is the true solubility advantage for amorphous pharmaceuticals? Pharmaceutical Research, 17, pp. 397-404.
15. Lee, J. H., Gi, U.-S., Kim, J.-H., Kim, Y., Kim, S.-H., Oh, H. and Min, B. (2001) Preparation and characterization of solvent induced dihydrated, anhydrous, and amorphous paclitaxel. The Bulletin of the Korean Chemical Society, 22, pp. 925-928.
16. Janicki, S., Sznitowska, M., Karas, W., Mroczek, Z., Tyrala, A. and Czarnecka, I.
17. Sharma, A. P., Sarkar, S. and Mahanty, J. S. (2005) Process for Preparation of Paclitaxel Trihydrate and Docetaxel Trihydrate
18. Choi, H.-K., Adams, T. L., Stahlhut, W., Kim, S.-I., Yun, J.-H., Song, B.-K., Kim, J.-H., Song, J.-S., Hong, S.-S. and Lee, H.-S. (1999) Method for Mass Production of Taxol by Semi-Continuous Culture with chinensis Cell Culture
19. Pyo, S. H., Park, H. B., Song, B. K., Han, B. H. and Kim, J. H. (2004) A large-scale purification of paclitaxel from cell cultures of Taxus chinensis. Process Biochemistry, 39, pp. 1985-1991.
20. Pyo, S. H., Kim, M. S., Cho, J. S., Song, B. K., Han, B. H. and Choi, H. J. (2004) An efficient purification and morphology characterization of paclitaxel from cell cultures of Taxus chinensis. Journal of Chemical Technology and Biotechnology, 79, pp. 1162-1168.
21. Authelin, J.-R., Doveze, J., Fouque, E., Mandard, B. and Taillepied, I.
22. Li, J. and Wu, Z.
23. Desai, K. G. H. and Park, H. J. (2004) Solubility studies on valdecoxib in the presence of carriers, cosolvents, and surfactants. Drug Development Research, 62, pp. 41-48.
24. Savolainen, J., Forsberg, M., Taipale, H., Männistö, P. T., Järvinen, K., Gynther, J., Jarho, P. and Järvinen, T. (2000) Effects of aqueous solubility and dissolution characteristics on oral bioavailability of entacapone. Drug Development Research, 49, pp. 238-244.
25. Liu, C., Desai, K. G. H., Liu, C. and Park, H. J. (2004) Enhancement of dissolution rate of rofecoxib using solid dispersions with urea. Drug Development Research, 63, pp. 181-189.
26. Panchagnula, R. (1998) Pharmaceutical aspects of paclitaxel. International Journal of Pharmaceutics, 172, pp. 1-15.
27. Singla, A. K., Garg, A. and Aggarwal, D. (2002) Paclitaxel and its formulation. International Journal of Pharmaceutics, 235, pp. 179-192.